Immunosuppressive therapy may affect the number of circulating regulatory cells in systemic sclerosis: Pay attention to the patient selection criteria.
Antiga
Emiliano
E
Fabbri
Paolo
P
Caproni
Marzia
M
D015704:CD4 Antigens / Q000096:biosynthesis; D002452:Cell Count; D051858:Forkhead Transcription Factors / Q000096:biosynthesis; D006801:Humans; D007165:Immunosuppression Therapy / Q000009:adverse effects; D053645:Interleukin-2 Receptor alpha Subunit / Q000096:biosynthesis; D018579:Patient Selection; D012595:Scleroderma, Systemic / Q000188:drug therapy* / Q000473:pathology / Q000503:physiopathology; D013256:Steroids / Q000009:adverse effects / Q000627:therapeutic use*; D050378:T-Lymphocytes, Regulatory / Q000187:drug effects* / Q000276:immunology / Q000378:metabolism / Q000473:pathology
D015704:CD4 Antigens; C418974:FOXP3 protein, human; D051858:Forkhead Transcription Factors; D053645:Interleukin-2 Receptor alpha Subunit; D013256:Steroids